Vestibular stimulation for promoting development and preventing morbidity in preterm infants

Marcus Glenton Prescott; Katarzyna Wróblewska-Seniuk; Mikaela Lenells; Michelle Fiander; Roger Soll; Matteo Bruschettini

doi:10.1002/14651858.CD016072

Vestibular stimulation for promoting development and preventing morbidity in preterm infants

Cochrane Database Syst Rev. 2024 Sep 5;9(9):CD016072. doi: 10.1002/14651858.CD016072.

Authors

Marcus Glenton Prescott¹, Katarzyna Wróblewska-Seniuk², Mikaela Lenells^{3

4}, Michelle Fiander⁵, Roger Soll⁶, Matteo Bruschettini⁷

Affiliations

¹ St. Olavs Hospital, Trondheim, Norway.
² II Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
³ Women and Children's Health, Karolinska Institute, Stockholm, Sweden.
⁴ FoUU, Karolinska University Hospital, Stockholm, Sweden.
⁵ Cochrane Neonatal Group, Halifax, Canada.
⁶ Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
⁷ Cochrane Sweden, Department of Research and Education, Lund University, Skåne University Hospital, Lund, Sweden.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of vestibular stimulation compared to standard care or non-vestibular stimulation for physical and neurological development in preterm infants. To assess whether the effects of vestibular stimulation differ according to gestational age at birth; the type, frequency, and duration of the intervention; and settings, such as the country where the study is conducted.

MeSH terms

Child Development*
Gestational Age
Humans
Infant, Newborn
Infant, Premature*
Randomized Controlled Trials as Topic
Vestibule, Labyrinth